RecruitingPhase 3NCT06617325A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusSponsor: UCB Biopharma SRLBellaire, TX · El Paso, TX · Fort Worth, TX · +60 more sites
RecruitingPhase 3NCT06133972Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).Sponsor: Novartis PharmaceuticalsBellaire, TX · League City, TX · Red Oak, TX · +22 more sites
RecruitingPhase 4NCT07611214PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus NephritisSponsor: Aurinia Pharmaceuticals Inc.Bellaire, TX · Dallas, TX · El Paso, TX · +24 more sites
RecruitingPhase 3NCT07201129A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular TreatmentSponsor: Viatris Innovation GmbHBellaire, TX · El Paso, TX · Houston, TX · +11 more sites